|
1
|
Cooperberg MR, Broering JM and Carroll PR:
Time trends and local variation in primary treatment of localized
prostate cancer. J Clin Oncol. 28:1117–1123. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wilt TJ, Brawer MK, Jones KM, Barry MJ,
Aronson WJ, Fox S, Gingrich JR, Wei JT, Gilhooly P, Grob BM, et al:
Prostate Cancer Intervention versus Observation Trial (PIVOT) Study
Group: Radical prostatectomy versus observation for localized
prostate cancer. N Engl J Med. 367:203–213. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rifkin MD: MRI of the prostate. Crit Rev
Diagn Imaging. 31:223–262. 1990.PubMed/NCBI
|
|
4
|
Tempany CM, Zhou X, Zerhouni EA, Rifkin
MD, Quint LE, Piccoli CW, Ellis JH and McNeil BJ: Staging of
prostate cancer: Results of Radiology Diagnostic Oncology Group
project comparison of three MR imaging techniques. Radiology.
192:47–54. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wolf JS Jr, Cher M, Dall'era M, Presti JC
J, Hricak H and Carroll PR: The use and accuracy of cross-sectional
imaging and fine needle aspiration cytology for detection of pelvic
lymph node metastases before radical prostatectomy. J Urol.
153:993–999. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Oesterling JE, Jacobsen SJ, Klee GG,
Pettersson K, Piironen T, Abrahamsson PA, Stenman UH, Dowell B,
Lövgren T and Lilja H: Free, complexed and total serum prostate
specific antigen: The establishment of appropriate reference ranges
for their concentrations and ratios. J Urol. 154:1090–1095. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Epstein JI, Allsbrook WC Jr, Amin MB and
Egevad LL: ISUP Grading Committee: The 2005 International Society
of Urological Pathology (ISUP) consensus conference on Gleason
grading of prostatic carcinoma. Am J Surg Pathol. 29:1228–1242.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
D'Amico AV, Whittington R, Malkowicz SB,
Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA,
Kaplan I, Beard CJ and Wein A: Biochemical outcome after radical
prostatectomy, external beam radiation therapy, or interstitial
radiation therapy for clinically localized prostate cancer. JAMA.
280:969–974. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Smith JA Jr: Radical prostatectomy for low
risk carcinoma of the prostate. World J Urol. 26:443–446. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bolla M, Collette L, Blank L, Warde P,
Dubois JB, Mirimanoff RO, Storme G, Bernier J, Kuten A, Sternberg
C, et al: Long-term results with immediate androgen suppression and
external irradiation in patients with locally advanced prostate
cancer (an EORTC study): a phase III randomised trial. Lancet.
360:103–106. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
D'Amico AV, Manola J, Loffredo M, Renshaw
AA, DellaCroce A and Kantoff PW: 6-month androgen suppression plus
radiation therapy vs radiation therapy alone for patients with
clinically localized prostate cancer: a randomized controlled
trial. JAMA. 292:821–827. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pierorazio PM, Ross AE, Lin BM, Epstein
JI, Han M, Walsh PC, Partin AW, Pavlovich CP and Schaeffer EM:
Preoperative characteristics of high-Gleason disease predictive of
favourable pathological and clinical outcomes at radical
prostatectomy. BJU Int. 110:1122–1128. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Epstein JI, Allsbrook WC Jr, Amin MB and
Egevad LL: ISUP Grading Committee: The 2005 International Society
of Urological Pathology (ISUP) consensus conference on Gleason
grading of prostatic carcinoma. Am J Surg Pathol. 29:1228–1242.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sobin LH, Gospodarowicz MK and Wittekind
Ch: Urological Tumors. TNM Classification of Malignant Tumors
(7th). Wiley-Blackwell. (Oxford). 243–248. 2009.
|
|
15
|
The Japanese Urological Association (eds):
Surgical Therapy. In: Clinical Practice Guidelines for Prostate
Cancer in Japan. 2012 version. Kanehara-shuppan Press. (Tokyo).
115–117. 2012.
|
|
16
|
Roehl KA, Han M, Ramos CG, Antenor JA and
Catalona WJ: Cancer progression and survival rates following
anatomical radical retropubic prostatectomy in 3,478 consecutive
patients: Long-term results. J Urol. 172:910–914. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Porter CR, Kodama K, Gibbons RP, Correa R
Jr, Chun FK, Perrotte P and Karakiewicz PI: 25-year prostate cancer
control and survival outcomes: A 40-year radical prostatectomy
single institution series. J Urol. 176:569–574. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Isbarn H, Wanner M, Salomon G, Steuber T,
Schlomm T, Köllermann J, Sauter G, Haese A, Heinzer H, Huland H and
Graefen M: Long-term data on the survival of patients with prostate
cancer treated with radical prostatectomy in the prostate-specific
antigen era. BJU Int. 106:37–43. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Suardi N, Porter CR, Reuther AM, Walz J,
Kodama K, Gibbons RP, Correa R, Montorsi F, Graefen M, Huland H, et
al: A nomogram predicting long-term biochemical recurrence after
radical prostatectomy. Cancer. 112:1254–1263. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Carver BS, Bianco FJ Jr, Scardino PT and
Eastham JA: Long-term outcome following radical prostatectomy in
men with clinical stage T3 prostate cancer. J Urol. 176:564–568.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gontero P, Marchioro G, Pisani R,
Zaramella S, Sogni F, Kocjancic E, Mondaini N, Bonvini D, Tizzani A
and Frea B: Is radical prostatectomy feasible in all cases of
locally advanced non-bone metastatic prostate cancer? Results of a
single-institution study. Eur Urol. 51:922–929. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Van Poppel H and Joniau S: An analysis of
radical prostatectomy in advanced stage and high-grade prostate
cancer. Eur Urol. 53:253–259. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Miocinovic R, Berglund RK, Stephenson AJ,
Jones JS, Fergany A, Kaouk J and Klein EA: Avoiding androgen
deprivation therapy in men with high-risk prostate cancer: The role
of radical prostatectomy as initial treatment. Urology. 77:946–950.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Catalona WJ, Smith DS and Ornstein DK:
Prostate cancer detection in men with serum PSA concentrations of
2.6 to 4.0 ng/ml and benign prostate examination. Enhancement of
specificity with free PSA measurements. JAMA. 277:1452–1455. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rietbergen JB, Hoedemaeker RF, Kruger AE,
Kirkels WJ and Schröder FH: The changing pattern of prostate cancer
at the time of diagnosis: Characteristics of screen detected
prostate cancer in a population based screening study. J Urol.
161:1192–1198. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gleason DF and Mellinger GT: Prediction of
prognosis for prostatic adenocarcinoma by combined histological
grading and clinical staging. J Urol. 111:58–64. 1974.PubMed/NCBI
|
|
27
|
McNeal JE, Villers AA, Redwine EA, Freiha
FS and Stamey TA: Histologic differentiation, cancer volume, and
pelvic lymph node metastasis in adenocarcinoma of the prostate.
Cancer. 66:1225–1233. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Epstein JI, Pizov G and Walsh PC:
Correlation of pathologic findings with progression after radical
retropubic prostatectomy. Cancer. 71:3582–3593. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chan TY, Partin AW, Walsh PC and Epstein
JI: Prognostic significance of Gleason score 3+4 versus Gleason
score 4+3 tumor at radical prostatectomy. Urology. 56:823–827.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wein AJ, Kavoussi LR, Novick AC, Partin
AW, Peters CA and Ramchandani P: Prostate cancer tumor markers.
Campbell-Walsh urology tenth edition review. McDougal SW: (10th).
Elsevier Saunders. (Philadelphia, PA). 2748–2770. 2011.
|
|
31
|
Gosselaar C, Roobol MJ, Roemeling S and
Schröder FH: The role of the digital rectal examination in
subsequent screening visits in the European randomized study of
screening for prostate cancer (ERSPC), Rotterdam. Eur Urol.
54:581–588. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Borden LS Jr, Wright JL, Kim J,
Latchamsetty K and Porter CR: An abnormal digital rectal
examination is an independent predictor of Gleason > or =7
prostate cancer in men undergoing initial prostate biopsy: A
prospective study of 790 men. BJU Int. 99:559–563. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Okotie OT, Roehl KA, Han M, Loeb S, Gashti
SN and Catalona WJ: Characteristics of prostate cancer detected by
digital rectal examination only. Urology. 70:1117–1120. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Thompson IM, Ankerst DP, Chi C, Goodman
PJ, Tangen CM, Lucia MS, Feng Z, Parnes HL and Coltman CA Jr:
Assessing prostate cancer risk: Results from the prostate cancer
prevention trial. J Natl Cancer Inst. 98:529–534. 2006. View Article : Google Scholar : PubMed/NCBI
|
